Hello Friends!
With the market looking a bit oversold, I went ahead and pushed my rules a bit and put in an order to buy 600 Somanetics (SMTS) at the market this morning. Somanetics came out with good earnings results this morning and with the 50% decrease in stroke rate reported associated with the use of their Cerebral oxygen monitoring during open heart surgery, this appears to be a company with all the ducks in a row as they say.
Please do your own due diligence and consult with your investment advisor before making any decisions based on information published here. If you have any questions, comments, or words of encouragement, please feel free to email me at bobsadviceforstocks@lycos.com
Regards!
Bob